Detalhe da pesquisa
1.
Improved nationwide survival of sarcoma patients with a network of reference centers.
Ann Oncol
; 35(4): 351-363, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246351
2.
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Eur J Cancer
; 196: 113454, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008029
3.
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.
ESMO Open
; 8(3): 101569, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285716
4.
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
Eur J Cancer
; 192: 113262, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625241
5.
Successful switch to dabrafenib after vemurafenib-induced toxic epidermal necrolysis.
Br J Dermatol
; 172(5): 1454-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25384395